TABLE 1.

Concurrent alterations identified in patients

Case 1 (alteration, allele frequency)	Case 2 (alteration, allele frequency)
STRN:exon3~ALK:exon20 (25.9%)	LMO7:exon15~ALK:exon20 (15.3%)
MET amplification (3.8‐fold)	NRG1:c.602A>T (21.0%)
TP53:c.991C>T (6.3%)	TP53:c.314G>A (2.2%)
TP53:c.742C>7 (26.8%)	TP53:c.140del (1.4%)
BRCA1:c.5347A>C (4.6%)	TP53:c.637C>T (0.9%)
BRCA2:c.7835C>A (3.8%)
FANCM:c.3296G>A (6.1%)
IDH1:c.940C>T (4.2%)
LRP1B:c.139T>C (3.3%)
MSH6:c.1589A>G (2.8%)
NTRK2:c.718_719del (5.3%)
PMS1:c.2417C>G (5.1%)
PTPN13:c.2516C>T (17.2%)